Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Commitments (Details Textual)

v3.8.0.1
Note 15 - Commitments (Details Textual)
1 Months Ended 3 Months Ended
Jan. 01, 2005
shares
Mar. 31, 2018
USD ($)
Feb. 28, 2018
USD ($)
Jan. 31, 2018
Jan. 31, 2017
Mar. 31, 2018
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2017
USD ($)
Advances on Inventory Purchases   $ 984,408       $ 984,408   $ 697,192
Additional Percentage of Director Compensation on Sales Value Using Certain Specify Technology 2.50%              
Additional Percentage of Director Compensation Sales Value Using Other Kind of Technology 5.00%              
Professional Fees           68,751    
Consulting Services [Member]                
Related Party Transaction, Expenses from Transactions with Related Party           50,000 $ 50,000  
Innovest S.p.A. [Member] | Consulting Services [Member]                
Related Party Transaction, Expenses from Transactions with Related Party           20,000 20,000  
Former CEO [Member]                
Employee Resignation Assertion, Gross Settlement     $ 175,000          
Employee Resignation Assertion, Payment   80,555            
Director of Clinical Affairs [Member]                
Stock Issued During Period, Shares, Stock Options Exercised, Attributable to Consultants | shares 8,333              
Royalty Expense           85,769 131,908  
Professional Fees             $ 68,751  
Instruments [Member]                
Purchase Commitment Number Of Units         2,000      
Purchase Commitment, Remaining Minimum Amount Committed   186,965       186,965    
Devices [Member]                
Purchase Commitment Number Of Units       2,000        
Purchase Commitment, Remaining Minimum Amount Committed   $ 1,397,440       $ 1,397,440